Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Panasonic acquires autonomous supply chain firm Blue Yonder

By Brian Buntz | September 17, 2021

Panasonic/BlueYonderPanasonic (TYO: 6752) has announced that it has wrapped up its acquisition of Blue Yonder, a supply chain management company established in Scottsdale, Arizona.

Both companies had similar plans for developing autonomous supply chain technology. The partnership will pair Panasonic’s sensing technology with the edge computing and machine learning capabilities of Blue Yonder.

Having acquired a 20% stake in the company in July 2020, Panasonic now owns 80% of Blue Yonder shares.

Blue Yonder’s most recent valuation was $8.5 billion.

Supply chain disruptions have grown more common during the pandemic, forcing many manufacturers including in the pharmaceutical industry to rethink their logistics strategy.

Part of the promise of autonomous supply chains is their resilience.

“Panasonic’s resources and Blue Yonder’s innovation will accelerate the development of the tools customers need to anticipate and prevent disruptions and breathe autonomy into their supply chains,” said Simon Ellis, program vice president at IDC, in a statement.

Following the acquisition, Panasonic will preserve the Blue Yonder brand and retain the company’s leadership team.

Tell Us What You Think! Cancel reply

Related Articles Read More >

A Zipline fixed-wing drone in the air drops a package
Cardinal Health starts Zipline drone deliveries of drugs and medical supplies
Pfizer logo
Pfizer to spend $120M to make COVID-19 oral treatment in U.S.
Image of MedTrace Pharma's P3 automated delivery system for 15-O water in action
MedTrace Pharma moves forward on 15 O-water imaging tech
coronavirus COVID-19 Pfizer
NIH starts evaluating second COVID-19 booster shots in adults

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards